APOA1 and myocardial infarction: Elevated IgG anti-apoA-1 levels are found in patients with acute coronary syndromes [9], are a risk factor for major cardiovascular events in the 12 months after myocardial infarction [10] and are associated with significantly increased risk of major cardiovascular events in patients with rheumatoid arthritis (RA) [11].